GOSSELIES, Belgium, March 05, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation ...
Cardiovascular disease (CVD) is the leading cause of death and disease burden worldwide. Macrophages are important components ...
From the approval of the first immune checkpoint inhibitors to the development of chimeric antigen receptor T cells, immunotherapy has demonstrated ...
Basophils trigger a cytokine cascade that improves antitumor immunity in mice, offering potential targets for cancer ...
This study combines mathematical models and experimental data to analyse the emergence of heterogeneity within clonal NK cell responses during antigen-specific cell expansion. Although it comprises ...
An immune profile consistent with the eactivation of the Epstein-Barr virus was observed in MS patients prior to a disease ...
Clinical research has long focused on ways to harness the actions of the immune system. From vaccines to immunotherapies, ...
Even for plants, there can be too much of a good thing. When nitrogen levels are too high, for example due to excessive ...
The move forms part of ELC’s newly unveiled Beauty Reimagined strategic vision, which aims to help the company return to ...
Researchers at the University of Pennsylvania and international collaborators have shown that innate immune training, also ...
A team of Yale School of Medicine infectious diseases researchers recently conducted an in-depth review of the literature on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback